PolyMedix, Inc.(fka PYMXQ)

[ziploc_1]

When Aegis capitol was chosen to underwrite a secondary offering, it was not a deal, which advanced cash to PYMX. Aegis did not accept the financial risks of selling the stock to investors, but it apparently was a "best efforts deal". This should have been made known to investors, but was not. It was this aspect of the deal which made the company unable to pay its debt and steered the company into bankruptcy.